The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

According to a Thursday update on the government’s vaccine portal, Health Canada will replace the older version of the ...

NACI added that anyone above 6 months of age who isn't considered high risk "may receive the most recently updated vaccine in ...

Moderna (MRNA) advanced over +4% and was the top percentage gainer on the Nasdaq 100 after announcing that Health Canada approved its updated COVID-19 vaccine, SPIKEVAX KP.2 variant, for preventing ...

Health Canada has authorized Moderna's updated COVID-19 vaccine to roll out in fall immunization campaigns. The new Spikevax ...

Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity ...

The company reported Health Canada authorized the use of its Spikevax KP.2 shot for those aged six months and older. Last ...

Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 ...

The KP.3 variant of SARS-CoV-2 is dominating in Canada right now, accounting for the majority of the COVID-19 cases in the ...

Moderna said that the Canadian government has approved its updated Covid-19 Spikevax for individuals aged six months and older. The biotechnology company on Tuesday said that Health Canada authorized ...

SPIKEVAX® is the first updated COVID-19 vaccine authorized in Canada for 2024-2025, offering a timely solution to help protect Canadians this fall and winter season.